Digital behavioural signatures reveal trans-diagnostic clusters of schizophrenia and Alzheimer's disease patients

Martien J.H. Kas*, Niels Jongs, Maarten Mennes, Brenda W.J.H. Penninx, Celso Arango, Nic van der Wee, Inge Winter-van Rossum, Jose Luis Ayuso-Mateos, Amy C. Bilderbeck, Philippe l'Hostis, Christian F. Beckmann, Gerard R. Dawson, Bernd Sommer, Hugh M. Marston

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

28 Downloads (Pure)


The current neuropsychiatric nosological categories underlie pragmatic treatment choice, regulation and clinical research but does not encompass biological rationale. However, subgroups of patients suffering from schizophrenia or Alzheimer's disease have more in common than the neuropsychiatric nature of their condition, such as the expression of social dysfunction. The PRISM project presents here initial quantitative biological insights allowing the first steps toward a novel trans-diagnostic classification of psychiatric and neurological symptomatology intended to reinvigorate drug discovery in this area. In this study, we applied spectral clustering on digital behavioural endpoints derived from passive smartphone monitoring data in a subgroup of Schizophrenia and Alzheimer's disease patients, as well as age matched healthy controls, as part of the PRISM clinical study. This analysis provided an objective social functioning characterization with three differential clusters that transcended initial diagnostic classification and was shown to be linked to quantitative neurobiological parameters assessed. This emerging quantitative framework will both offer new ways to classify individuals in biologically homogenous clusters irrespective of their initial diagnosis, and also offer insights into the pathophysiological mechanisms underlying these clusters.

Originele taal-2English
Pagina's (van-tot)3-12
Aantal pagina's10
TijdschriftEuropean Neuropsychopharmacology
StatusPublished - jan.-2024

Citeer dit